The authors investigated a mix of established thrombophilias (ie, deficiencies of antithrombin, protein C and protein S, and antiphospholipid antibodies) as well as plasma levels of some coagulation factors (factor [F]VIII, FIX, and fibrinogen) and homocysteine. This evidence concerns the gene PROS1 and Rare hereditary thrombophilia.